Controversies in sepsis clinical trials: proceedings of a meeting of the International Sepsis Forum, Lausanne, Switzerland, September 29, 2001

R. Phillip Dellinger; Edward Abraham; Gordon R. Bernard; John Marshall; Jean Louis Vincent

doi:10.1016/j.jcrc.2005.07.002

Back

Controversies in sepsis clinical trials: proceedings of a meeting of the International Sepsis Forum, Lausanne, Switzerland, September 29, 2001

Article 2006 en

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Letter2002

The International Sepsis Forum's controversies in sepsis: my initial vasopressor agent in septic shock is dopamine rather than norepinephrine.

Jean Louis Vincent, Daniel De Backer

Article2005

Outcome measures for clinical research in sepsis: A report of the 2nd Cambridge Colloquium of the International Sepsis Forum

John C. Marshall, Jean Louis Vincent, Gordon Guyatt, Derek C. Angus, Edward Abraham, Gordon R. Bernard, Claire Bombardier, Thierry Calandra, Henrik Jørgensen, Richard Sylvester, Maarten Boers

Article2003

The International Sepsis Forum's frontiers in sepsis: High cardiac output should be maintained in severe sepsis.

Jean Louis Vincent

Article2001

PCIM'2001 : Proceedings of the International Intelligent Motion (Motor-Con) Conference, Nürnberg, Germany, June, 2001

Book1990

Abstracts of papers presented at the 1990 Meeting on Mouse Molecular Genetics, August 29-September 2, 1990

Douglas Hanahan, Richard D. Palmiter, Erwin F. Wagner